153 related articles for article (PubMed ID: 27824418)
1. [Specifics for anticoagulation with atrial fibrillation: triple therapy and perioperative bridging].
Frantz S
Dtsch Med Wochenschr; 2016 Oct; 141(22):1624-1627. PubMed ID: 27824418
[TBL] [Abstract][Full Text] [Related]
2. Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxis.
Garton AB; Dudzinski J; Kowey PR
J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1411-8. PubMed ID: 25216104
[TBL] [Abstract][Full Text] [Related]
3. [Not Available].
Unfallchirurg; 2016 Jul; 119(7):542-3. PubMed ID: 27422125
[No Abstract] [Full Text] [Related]
4. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
Wysokinski WE; McBane RD; Daniels PR; Litin SC; Hodge DO; Dowling NF; Heit JA
Mayo Clin Proc; 2008 Jun; 83(6):639-45. PubMed ID: 18533080
[TBL] [Abstract][Full Text] [Related]
5. Low dose dabigatran versus uninterrupted acenocoumarol for peri-procedural anticoagulation in atrial fibrillation catheter ablation.
Efremidis M; Vlachos K; Letsas KP; Giannopoulos G; Lioni L; Georgopoulos S; Vadiaka M; Deftereos S; Sideris A
J Electrocardiol; 2015; 48(5):840-4. PubMed ID: 26152604
[TBL] [Abstract][Full Text] [Related]
6. [DO's and DON'Ts: Perioperative management with vitamin-K-independent anticoagulants].
Koscielny J
Dtsch Med Wochenschr; 2015 Jun; 140 Suppl 1():S15-7. PubMed ID: 26069040
[No Abstract] [Full Text] [Related]
7. Anticoagulation therapy: Perioperative anticoagulation-are we at 'a bridge too far'?
Douketis JD
Nat Rev Cardiol; 2015 Mar; 12(3):133-4. PubMed ID: 25645499
[TBL] [Abstract][Full Text] [Related]
8. Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.
Daniels PR; McBane RD; Litin SC; Ward SA; Hodge DO; Dowling NF; Heit JA
Thromb Res; 2009 Jul; 124(3):300-5. PubMed ID: 19232682
[TBL] [Abstract][Full Text] [Related]
9. [Perioperative management of atrial fibrillation].
Arguis MJ; Navarro R; Regueiro A; Arbelo E; Sierra P; Sabaté S; Galán J; Ruiz A; Matute P; Roux C; Gomar C; Rovira I; Mont L; Fita G
Rev Esp Anestesiol Reanim; 2014 May; 61(5):262-71. PubMed ID: 23522980
[TBL] [Abstract][Full Text] [Related]
10. [Pre-interventional, peri-interventional and post-interventional anticoagulation in the setting of catheter ablation for atrial fibrillation : current practice and practical approach].
Antz M; Willems S; Hoffmann BA
Herz; 2015 Feb; 40(1):45-9. PubMed ID: 25645235
[TBL] [Abstract][Full Text] [Related]
11. Effects of Triple Therapy in Patients With Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Regarding Thromboembolic Risk Stratification.
Sambola A; Mutuberría M; García Del Blanco B; Alonso A; Barrabés JA; Alfonso F; Bueno H; Cequier A; Zueco J; Rodríguez-Leor O; Bosch E; Tornos P; García-Dorado D
Circ J; 2016; 80(2):354-62. PubMed ID: 26725763
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation in atrial fibrillation: a contemporary viewpoint.
Wyse DG
Heart Rhythm; 2007 Mar; 4(3 Suppl):S34-9. PubMed ID: 17336882
[TBL] [Abstract][Full Text] [Related]
13. Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management.
Weltermann A; Brodmann M; Domanovits H; Eber B; Gottsauner-Wolf M; Halbmayer WM; Hiesmayr JM; Kyrle PA; Längle F; Roithinger FX; Watzke H; Windhager R; Wolf C; Zweiker R
Wien Klin Wochenschr; 2012 May; 124(9-10):340-7. PubMed ID: 22576960
[TBL] [Abstract][Full Text] [Related]
14. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial.
Sambola A; Montoro JB; Del Blanco BG; Llavero N; Barrabés JA; Alfonso F; Bueno H; Cequier A; Serra A; Zueco J; Sabaté M; Rodríguez-Leor O; García-Dorado D
Am Heart J; 2013 Oct; 166(4):669-75. PubMed ID: 24093846
[TBL] [Abstract][Full Text] [Related]
15. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
Garwood CL; Hwang JM; Moser LR
Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation in atrial fibrillation: NOAC's the word.
Werdan K; Braun-Dullaeus R; Presek P
Dtsch Arztebl Int; 2013 Aug; 110(31-32):523-4. PubMed ID: 24069072
[No Abstract] [Full Text] [Related]
17. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
Douketis JD; Healey JS; Brueckmann M; Eikelboom JW; Ezekowitz MD; Fraessdorf M; Noack H; Oldgren J; Reilly P; Spyropoulos AC; Wallentin L; Connolly SJ
Thromb Haemost; 2015 Mar; 113(3):625-32. PubMed ID: 25472710
[TBL] [Abstract][Full Text] [Related]
18. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
[TBL] [Abstract][Full Text] [Related]
19. Therapy Insight: management of urology patients taking long-term warfarin anticoagulation therapy.
Daniels PR
Nat Clin Pract Urol; 2005 Jul; 2(7):343-50. PubMed ID: 16474787
[TBL] [Abstract][Full Text] [Related]
20. The use of anticoagulation during the periprocedure period of atrial fibrillation ablation.
Verma A; Tsang B
Curr Opin Cardiol; 2012 Jan; 27(1):55-61. PubMed ID: 22146378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
